Johnson & Johnson completes $6.5B takeover of Momenta
In autoimmune diseases, the antibodies attack or damage proteins, cells and tissues in the host's body, J&J said, adding that they can often have "devastating consequences."
Friday, October 2, 2020
Johnson & Johnson completes $6.5B takeover of Momenta
Johnson & Johnson completes $6.5B takeover of Momenta
In autoimmune diseases, the antibodies attack or damage proteins, cells and tissues in the host's body, J&J said, adding that they can often have "devastating consequences."
0 comments:
Post a Comment